SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ajanta Pharma informs about board meeting

23 Oct 2020 Evaluate
Pursuant to Regulation 29 of the Listing Regulations, Ajanta Pharma has informed that the meeting of the Board of Directors of the Company is scheduled on 03/11/2020 to consider and approve take on record unaudited consolidated & standalone Financial Results of the Company for the second quarter and half year ended 30th September 2020 and consider declaration of interim dividend.

The above information is a part of company’s filings submitted to BSE. 


Ajanta Pharma Share Price

3305.10 127.20 (4.00%)
29-Jun-2026 12:54 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1880.55
Dr. Reddys Labs. 1382.80
Cipla 1475.00
Zydus Lifesciences 1116.00
Lupin 2386.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: